These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6237929)

  • 21. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and characterization of human leukemia-associated antigens on leukemic cell lines and thymocytes. I. Characterization of baboon and rabbit antisera to MOLT-4.
    Yoshizaki K; Seon BK; Barcos MP; Minowada J; Pressman D
    J Immunol; 1979 May; 122(5):1943-50. PubMed ID: 109520
    [No Abstract]   [Full Text] [Related]  

  • 23. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
    Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC; Hank JA; Gan J; Sondel PM
    Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variables affecting the killing of cultured human neuroblastoma cells with monoclonal antibody and complement.
    Duerst RE; Ryan DH; Frantz CN
    Cancer Res; 1986 Jul; 46(7):3420-5. PubMed ID: 3708574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.
    Morishima Y; Kobayashi M; Yang SY; Collins NH; Hoffmann MK; Dupont B
    J Immunol; 1982 Sep; 129(3):1091-8. PubMed ID: 6980917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement-mediated lysis of K562 human leukemic cells by antibodies to phosphotyrosine and identification of cell surface proteins phosphorylated on tyrosine.
    Ogawa R; Ohtsuka M; Watanabe Y
    Cancer Res; 1986 May; 46(5):2507-10. PubMed ID: 2421879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
    Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
    Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-induced lysis of isolated rat epididymal adipocytes and complement activation in vivo.
    Dickinson K; North TJ; Telford G; Smith SE; Edwards BM; Main SH; Field R; Hatton D; Vaughan TJ; Flint DJ; Jones RB
    Obes Res; 2002 Feb; 10(2):122-7. PubMed ID: 11836458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
    Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
    J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cytolytic lymphocytes by homologous restriction factor. Lack of species restriction.
    Zalman LS; Brothers MA; Strauss KL
    J Immunol; 1991 Jun; 146(12):4278-81. PubMed ID: 1904077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the competitive capacity of monoclonal antibody sensitized human A and B erythrocytes in complement mediated cytotoxicity.
    Bakács T; Ringwald G; Tusnády G; Végh Z; Klein E
    J Clin Lab Immunol; 1990 Aug; 32(4):167-75. PubMed ID: 1966933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of antibody and complement in the cellular response to Trypanosoma congolense.
    Schmitz B; Gehrung M; Thornton M; Speth V
    Clin Exp Immunol; 1984 Apr; 56(1):73-80. PubMed ID: 6713731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of monoclonal antibodies reactive with porcine PBL.
    Pescovitz MD; Lunney JK; Sachs DH
    J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC; Youle RJ; Vallera DA
    Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.